Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BioAtla, Inc.BCAB · Entity 879 | Director | June 18, 2025 | June 18, 2025 |
| CELGENE CORP /DE/CELG · Entity 15781 | See Remarks | February 17, 2018 | February 20, 2018 |
| F-star Therapeutics, Inc.SBPH · Entity 115726 | Director | June 24, 2020 | June 25, 2020 |
| TITAN PHARMACEUTICALS INCTTNP · Entity 74432 | Director | September 15, 2017 | September 19, 2017 |
| Viatris IncVTRS · Entity 3277 | Director · Chief Executive Officer | March 06, 2026 | March 10, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BioAtla, Inc.
Report date June 18, 2025 · Filed June 18, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 321,550 |
Reported balance
After 2025-06-18 transaction · row 1
1 source rowRow 1 · 2025-06-18 · Grant · Acquired 23,500 · Balance 321,550 F1: Represents shares of Common Stock underlying a time-based restricted stock unit award ("RSU"). The RSU will vest as to 100% of the total number of shares on the earlier of (i) June 18, 2026, or (ii) the next Company annual meeting of stockholders, subject to the reporting person's continued service through the vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of Common Stock underlying a time-based restricted stock unit award ("RSU"). The RSU will vest as to 100% of the total number of shares on the earlier of (i) June 18, 2026, or (ii) the next Company annual meeting of stockholders, subject to the reporting person's continued service through the vesting date.
CELGENE CORP /DE/
Report date February 17, 2018 · Filed February 20, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 49,419 |
Ending reported balance
After 2018-02-17 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2018-02-17 · Exercise / conversion · Acquired 7,283 · Balance 51,748 F1: The performance stock units granted to the reporting person on February 13, 2018 vested and settled for shares of the Company's common stock. Row 2 · 2018-02-17 · Tax withholding · Disposed 2,329 · Balance 49,419 |
| Performance Stock UnitSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2018-02-17 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2018-02-17 · Exercise / conversion · Disposed 7,283 · Balance 0 F2: Each performance stock unit represents a contingent right to receive one share of the Company's common stock. F3: The performance stock units were issued pursuant to the Company's 2017 Stock Incentive Plan. F1: The performance stock units granted to the reporting person on February 13, 2018 vested and settled for shares of the Company's common stock. |
| Common StockSEC Table I · non-derivative | Indirect401(k) Plan | 2,788 |
Reported balance
Holding disclosure · report date 2018-02-17 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 2,788 |
Filing footnotes · ownership attribution and instrument terms
F1: The performance stock units granted to the reporting person on February 13, 2018 vested and settled for shares of the Company's common stock.
F2: Each performance stock unit represents a contingent right to receive one share of the Company's common stock.
F3: The performance stock units were issued pursuant to the Company's 2017 Stock Incentive Plan.
F-star Therapeutics, Inc.
Report date June 24, 2020 · Filed June 25, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.60 · Expires 2030-06-23 | Direct | 7,500 |
Reported balance
After 2020-06-24 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2020-06-24 · Grant · Acquired 7,500 · Balance 7,500 F1: Pursuant to the Issuer's Non-Employee Director Compensation Policy, this option was automatically granted on June 24, 2020, the date of the Issuer's 2020 Annual Meeting of Stockholder, with shares subject to the option vesting in equal monthly installments until the first anniversary of the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the Issuer's Non-Employee Director Compensation Policy, this option was automatically granted on June 24, 2020, the date of the Issuer's 2020 Annual Meeting of Stockholder, with shares subject to the option vesting in equal monthly installments until the first anniversary of the grant date.
TITAN PHARMACEUTICALS INC
Report date September 15, 2017 · Filed September 19, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Option to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $1.50 · Expires 2027-09-15 | Direct | 10,000 |
Reported balance
After 2017-09-15 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2017-09-15 · Grant · Acquired 10,000 · Balance 10,000 F1: The option vests in 12 equal monthly installments commencing as of September 1, 2017. |
Filing footnotes · ownership attribution and instrument terms
F1: The option vests in 12 equal monthly installments commencing as of September 1, 2017.
Viatris Inc
Report date March 06, 2026 · Filed March 10, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,329,326 |
Ending reported balance
After 2026-03-06 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2026-03-06 · Exercise / conversion · Acquired 124,519 · Balance 1,374,576 Row 2 · 2026-03-06 · Tax withholding · Disposed 48,999 · Balance 1,325,577 F1: Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the restricted stock units (RSUs) granted on March 6, 2025. Row 3 · 2026-03-06 · Exercise / conversion · Acquired 6,182 · Balance 1,331,759 F2: Fractional shares have been rounded up in connection with the settlement described in footnote 6 pursuant to the terms of the RSU award agreement under the Viatris Inc. 2020 Stock Incentive Plan. Row 4 · 2026-03-06 · Tax withholding · Disposed 2,433 · Balance 1,329,326 F3: Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the dividend equivalent units (DEUs) that accrued with respect to the RSUs previously granted on March 6, 2025. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 249,036 |
Reported balance
After 2026-03-06 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-03-06 · Exercise / conversion · Disposed 124,519 · Balance 249,036 F4: Each RSU represents the right to receive one share of common stock of Viatris Inc. (Viatris). 124,519 of the RSUs granted on March 6, 2025 vested on March 6, 2026 and 124,518 will vest on each of March 6, 2027 and March 6, 2028. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 256,074 |
Reported balance
After 2026-03-06 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-03-06 · Grant · Acquired 256,074 · Balance 256,074 F7: Each RSU represents the right to receive one share of common stock of Viatris. 85,358 of the RSUs granted on March 6, 2026 will vest on each of March 6, 2027, March 6, 2028, and March 6, 2029. |
| Dividend Equivalent UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 12,362 |
Reported balance
After 2026-03-06 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-03-06 · Exercise / conversion · Disposed 6,181.4237 · Balance 12,362 F5: Amount represents DEUs that accrued with respect to such RSUs in transactions exempt from Section 16 under Rule 16a-11. F6: Represents DEUs that accrued with respect to the RSUs previously granted on March 6, 2025 and vest on the same schedule as the underlying RSUs. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the restricted stock units (RSUs) granted on March 6, 2025.
F2: Fractional shares have been rounded up in connection with the settlement described in footnote 6 pursuant to the terms of the RSU award agreement under the Viatris Inc. 2020 Stock Incentive Plan.
F3: Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the dividend equivalent units (DEUs) that accrued with respect to the RSUs previously granted on March 6, 2025.
F4: Each RSU represents the right to receive one share of common stock of Viatris Inc. (Viatris). 124,519 of the RSUs granted on March 6, 2025 vested on March 6, 2026 and 124,518 will vest on each of March 6, 2027 and March 6, 2028.
F5: Amount represents DEUs that accrued with respect to such RSUs in transactions exempt from Section 16 under Rule 16a-11.
F6: Represents DEUs that accrued with respect to the RSUs previously granted on March 6, 2025 and vest on the same schedule as the underlying RSUs.
F7: Each RSU represents the right to receive one share of common stock of Viatris. 85,358 of the RSUs granted on March 6, 2026 will vest on each of March 6, 2027, March 6, 2028, and March 6, 2029.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Apexigen, Inc.
Report date August 23, 2023 · Filed August 25, 2023
Section 16 reporting ended · disclosed 2023-08-25. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $6.94 · Expires 2029-11-08 | Direct | 0 |
Reported balance
After 2023-08-23 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2023-08-23 · Disposition to issuer · Disposed 34,084 · Balance 0 F1: The shares subject to the option vest in 48 equal monthly installments beginning on September 16, 2019. Pursuant to an Agreement and Plan of Merger, dated as of May 23, 2023 (the "Merger Agreement"), by and among the Issuer, Pyxis Oncology, Inc. ("Pyxis"), and Ascent Merger Sub Corp., at the effective time of the merger (the "Effective Time"), the option was assumed by Pyxis and converted into an option to purchase 5,879 shares of Pyxis common stock at an exercise price of $40.24 per share. In accordance with the reporting person's equity award agreement, vesting of the unvested shares underlying the option accelerated in full at the Effective Time. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.65 · Expires 2032-09-29 | Direct | 0 |
Reported balance
After 2023-08-23 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2023-08-23 · Disposition to issuer · Disposed 100,000 · Balance 0 F2: The shares subject to the option vest in three equal annual installments beginning on July 29, 2023. Pursuant to the Merger Agreement, at the Effective Time, the option was assumed by Pyxis and converted into an option to purchase 17,250 shares of Pyxis common stock at an exercise price of $15.37 per share. In accordance with the reporting person's equity award agreement, vesting of the unvested shares underlying the option accelerated in full at the Effective Time. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares subject to the option vest in 48 equal monthly installments beginning on September 16, 2019. Pursuant to an Agreement and Plan of Merger, dated as of May 23, 2023 (the "Merger Agreement"), by and among the Issuer, Pyxis Oncology, Inc. ("Pyxis"), and Ascent Merger Sub Corp., at the effective time of the merger (the "Effective Time"), the option was assumed by Pyxis and converted into an option to purchase 5,879 shares of Pyxis common stock at an exercise price of $40.24 per share. In accordance with the reporting person's equity award agreement, vesting of the unvested shares underlying the option accelerated in full at the Effective Time.
F2: The shares subject to the option vest in three equal annual installments beginning on July 29, 2023. Pursuant to the Merger Agreement, at the Effective Time, the option was assumed by Pyxis and converted into an option to purchase 17,250 shares of Pyxis common stock at an exercise price of $15.37 per share. In accordance with the reporting person's equity award agreement, vesting of the unvested shares underlying the option accelerated in full at the Effective Time.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 06, 2026 Filed Mar 10, 2026 19:03 UTC | Viatris Inc VTRS · Entity 3277 | GrantRestricted Stock Units · Derivative | 256,074 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001140361-26-008887 · form4.xml · derivative · entry 7 Smith Scott Andrew · CIK 0001614975 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 256,074 Underlying: Common Stock · 256,074 shares Expires not disclosed F7 · derivative.exercise_date: Each RSU represents the right to receive one share of common stock of Viatris. 85,358 of the RSUs granted on March 6, 2026 will vest on each of March 6, 2027, March 6, 2028, and March 6, 2029. F7 · derivative.expiration_date: Each RSU represents the right to receive one share of common stock of Viatris. 85,358 of the RSUs granted on March 6, 2026 will vest on each of March 6, 2027, March 6, 2028, and March 6, 2029. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 19:03 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionDividend Equivalent Units · Derivative | 6,181.4237 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001140361-26-008887 · form4.xml · derivative · entry 6 Smith Scott Andrew · CIK 0001614975 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,362 Underlying: Common Stock · 6,181.4237 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · shares: Amount represents DEUs that accrued with respect to such RSUs in transactions exempt from Section 16 under Rule 16a-11. F6 · derivative.exercise_date: Represents DEUs that accrued with respect to the RSUs previously granted on March 6, 2025 and vest on the same schedule as the underlying RSUs. F6 · derivative.expiration_date: Represents DEUs that accrued with respect to the RSUs previously granted on March 6, 2025 and vest on the same schedule as the underlying RSUs. F5 · balance_after: Amount represents DEUs that accrued with respect to such RSUs in transactions exempt from Section 16 under Rule 16a-11. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 19:03 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionRestricted Stock Units · Derivative | 124,519 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001140361-26-008887 · form4.xml · derivative · entry 5 Smith Scott Andrew · CIK 0001614975 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 249,036 Underlying: Common Stock · 124,519 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Each RSU represents the right to receive one share of common stock of Viatris Inc. (Viatris). 124,519 of the RSUs granted on March 6, 2025 vested on March 6, 2026 and 124,518 will vest on each of March 6, 2027 and March 6, 2028. F4 · derivative.expiration_date: Each RSU represents the right to receive one share of common stock of Viatris Inc. (Viatris). 124,519 of the RSUs granted on March 6, 2025 vested on March 6, 2026 and 124,518 will vest on each of March 6, 2027 and March 6, 2028. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 19:03 UTC | Viatris Inc VTRS · Entity 3277 | Tax withholdingCommon Stock | 2,433 | $14.16 | $34,451.28 |
DisclosureSEC source: 0001140361-26-008887 · form4.xml · nonDerivative · entry 4 Smith Scott Andrew · CIK 0001614975 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,329,326 F3 · shares: Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the dividend equivalent units (DEUs) that accrued with respect to the RSUs previously granted on March 6, 2025. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 19:03 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionCommon Stock | 6,182 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-26-008887 · form4.xml · nonDerivative · entry 3 Smith Scott Andrew · CIK 0001614975 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,331,759 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Fractional shares have been rounded up in connection with the settlement described in footnote 6 pursuant to the terms of the RSU award agreement under the Viatris Inc. 2020 Stock Incentive Plan. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 19:03 UTC | Viatris Inc VTRS · Entity 3277 | Tax withholdingCommon Stock | 48,999 | $14.16 | $693,825.84 |
DisclosureSEC source: 0001140361-26-008887 · form4.xml · nonDerivative · entry 2 Smith Scott Andrew · CIK 0001614975 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,325,577 F1 · shares: Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the restricted stock units (RSUs) granted on March 6, 2025. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 19:03 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionCommon Stock | 124,519 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-26-008887 · form4.xml · nonDerivative · entry 1 Smith Scott Andrew · CIK 0001614975 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,374,576 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 04, 2026 Filed Mar 5, 2026 19:00 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionDividend Equivalent Units · Derivative | 8,713.6496 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001140361-26-008116 · form4.xml · derivative · entry 16 Smith Scott Andrew · CIK 0001614975 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,714 Underlying: Common Stock · 8,713.6496 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · shares: Amount represents DEUs that accrued with respect to such RSUs in transactions exempt from Section 16 under Rule 16a-11. F14 · derivative.exercise_date: Represents DEUs that accrued with respect to the RSUs previously granted on March 4, 2024 and vest on the same schedule as the underlying RSUs. F14 · derivative.expiration_date: Represents DEUs that accrued with respect to the RSUs previously granted on March 4, 2024 and vest on the same schedule as the underlying RSUs. F9 · balance_after: Amount represents DEUs that accrued with respect to such RSUs in transactions exempt from Section 16 under Rule 16a-11. Read SEC document |
| March 04, 2026 Filed Mar 5, 2026 19:00 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionRestricted Stock Units · Derivative | 92,503 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001140361-26-008116 · form4.xml · derivative · entry 15 Smith Scott Andrew · CIK 0001614975 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,503 Underlying: Common Stock · 92,503 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F13 · derivative.exercise_date: Each RSU represents the right to receive one share of common stock of Viatris. 92,503 of the RSUs granted on March 4, 2024 vested on each of March 4, 2025 and March 4, 2026 and 92,503 will vest on March 4, 2027. F13 · derivative.expiration_date: Each RSU represents the right to receive one share of common stock of Viatris. 92,503 of the RSUs granted on March 4, 2024 vested on each of March 4, 2025 and March 4, 2026 and 92,503 will vest on March 4, 2027. Read SEC document |
| March 04, 2026 Filed Mar 5, 2026 19:00 UTC | Viatris Inc VTRS · Entity 3277 | Tax withholdingCommon Stock | 3,429 | $14.71 | $50,440.59 |
DisclosureSEC source: 0001140361-26-008116 · form4.xml · nonDerivative · entry 10 Smith Scott Andrew · CIK 0001614975 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,250,057 F7 · shares: Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the DEUs that accrued with respect to the RSUs previously granted on March 4, 2024. Read SEC document |
| March 04, 2026 Filed Mar 5, 2026 19:00 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionCommon Stock | 8,714 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-26-008116 · form4.xml · nonDerivative · entry 9 Smith Scott Andrew · CIK 0001614975 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,253,486 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · shares: Fractional shares have been rounded up in connection with the settlement described in footnote 14 pursuant to the terms of the RSU award agreement under the Viatris Inc. 2020 Stock Incentive Plan. Read SEC document |
| March 04, 2026 Filed Mar 5, 2026 19:00 UTC | Viatris Inc VTRS · Entity 3277 | Tax withholdingCommon Stock | 36,400 | $14.71 | $535,444.00 |
DisclosureSEC source: 0001140361-26-008116 · form4.xml · nonDerivative · entry 8 Smith Scott Andrew · CIK 0001614975 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,244,772 F5 · shares: Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the RSUs granted on March 4, 2024. Read SEC document |
| March 04, 2026 Filed Mar 5, 2026 19:00 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionCommon Stock | 92,503 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-26-008116 · form4.xml · nonDerivative · entry 7 Smith Scott Andrew · CIK 0001614975 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,281,172 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 03, 2026 Filed Mar 5, 2026 19:00 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionPerformance Restricted Stock Units · Derivative | 1,286,849 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001140361-26-008116 · form4.xml · derivative · entry 14 Smith Scott Andrew · CIK 0001614975 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,286,849 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F12 · derivative.exercise_date: Each PRSU represents the right to receive one share of common stock of Viatris. The PRSUs were initially granted on April 1, 2023, subject to the attainment of previously established three-year performance goals and a vesting period. The PRSUs vested on March 3, 2026. F12 · derivative.expiration_date: Each PRSU represents the right to receive one share of common stock of Viatris. The PRSUs were initially granted on April 1, 2023, subject to the attainment of previously established three-year performance goals and a vesting period. The PRSUs vested on March 3, 2026. Read SEC document |
| March 03, 2026 Filed Mar 5, 2026 19:00 UTC | Viatris Inc VTRS · Entity 3277 | GrantPerformance Restricted Stock Units(11) · Derivative | 1,286,849 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001140361-26-008116 · form4.xml · derivative · entry 13 Smith Scott Andrew · CIK 0001614975 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,286,849 Underlying: Common Stock · 1,286,849 shares Expires not disclosed F11 · shares: Amount includes DEUs that accrued with respect to the PRSUs previously granted on April 1, 2023 and vest on the same schedule as the underlying PRSUs. Fractional shares with respect to such DEUs were rounded up pursuant to the terms of the PRSU award agreement under the Viatris Inc. 2020 Stock Incentive Plan. F12 · derivative.exercise_date: Each PRSU represents the right to receive one share of common stock of Viatris. The PRSUs were initially granted on April 1, 2023, subject to the attainment of previously established three-year performance goals and a vesting period. The PRSUs vested on March 3, 2026. F12 · derivative.expiration_date: Each PRSU represents the right to receive one share of common stock of Viatris. The PRSUs were initially granted on April 1, 2023, subject to the attainment of previously established three-year performance goals and a vesting period. The PRSUs vested on March 3, 2026. Read SEC document |
| March 03, 2026 Filed Mar 5, 2026 19:00 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionDividend Equivalent Units · Derivative | 18,153.1987 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001140361-26-008116 · form4.xml · derivative · entry 12 Smith Scott Andrew · CIK 0001614975 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,153.1987 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · shares: Amount represents DEUs that accrued with respect to such RSUs in transactions exempt from Section 16 under Rule 16a-11. F10 · derivative.exercise_date: Represents DEUs that accrued with respect to the RSUs previously granted on April 1, 2023 and vest on the same schedule as the underlying RSUs. F10 · derivative.expiration_date: Represents DEUs that accrued with respect to the RSUs previously granted on April 1, 2023 and vest on the same schedule as the underlying RSUs. Read SEC document |
| March 03, 2026 Filed Mar 5, 2026 19:00 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionRestricted Stock Units · Derivative | 135,828 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001140361-26-008116 · form4.xml · derivative · entry 11 Smith Scott Andrew · CIK 0001614975 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 135,828 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: Each RSU represents the right to receive one share of common stock of Viatris Inc. (Viatris). 135,829 of the RSUs granted on April 1, 2023 vested on March 3, 2024, 135,828 vested on March 3, 2025, and 135,828 vested on March 3, 2026. F8 · derivative.expiration_date: Each RSU represents the right to receive one share of common stock of Viatris Inc. (Viatris). 135,829 of the RSUs granted on April 1, 2023 vested on March 3, 2024, 135,828 vested on March 3, 2025, and 135,828 vested on March 3, 2026. Read SEC document |
| March 03, 2026 Filed Mar 5, 2026 19:00 UTC | Viatris Inc VTRS · Entity 3277 | Tax withholdingCommon Stock | 506,376 | $14.89 | $7,539,938.64 |
DisclosureSEC source: 0001140361-26-008116 · form4.xml · nonDerivative · entry 6 Smith Scott Andrew · CIK 0001614975 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,188,669 F4 · shares: Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of the performance restricted stock units (PRSUs) granted on April 1, 2023. Read SEC document |
| March 03, 2026 Filed Mar 5, 2026 19:00 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionCommon Stock | 1,286,849 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-26-008116 · form4.xml · nonDerivative · entry 5 Smith Scott Andrew · CIK 0001614975 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,695,045 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 03, 2026 Filed Mar 5, 2026 19:00 UTC | Viatris Inc VTRS · Entity 3277 | Tax withholdingCommon Stock | 7,144 | $14.89 | $106,374.16 |
DisclosureSEC source: 0001140361-26-008116 · form4.xml · nonDerivative · entry 4 Smith Scott Andrew · CIK 0001614975 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 408,196 F3 · shares: Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the dividend equivalent units (DEUs) that accrued with respect to the RSUs previously granted on April 1, 2023. Read SEC document |
| March 03, 2026 Filed Mar 5, 2026 19:00 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionCommon Stock | 18,154 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-26-008116 · form4.xml · nonDerivative · entry 3 Smith Scott Andrew · CIK 0001614975 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 415,340 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Fractional shares have been rounded up in connection with the settlement described in footnote 10 pursuant to the terms of the RSU award agreement under the Viatris Inc. 2020 Stock Incentive Plan. Read SEC document |
| March 03, 2026 Filed Mar 5, 2026 19:00 UTC | Viatris Inc VTRS · Entity 3277 | Tax withholdingCommon Stock | 53,449 | $14.89 | $795,855.61 |
DisclosureSEC source: 0001140361-26-008116 · form4.xml · nonDerivative · entry 2 Smith Scott Andrew · CIK 0001614975 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 397,186 F1 · shares: Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the restricted stock units (RSUs) granted on April 1, 2023. Read SEC document |
| March 03, 2026 Filed Mar 5, 2026 19:00 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionCommon Stock | 135,828 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-26-008116 · form4.xml · nonDerivative · entry 1 Smith Scott Andrew · CIK 0001614975 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 450,635 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 12, 2025 Filed Aug 13, 2025 18:08 UTC | Viatris Inc VTRS · Entity 3277 | PurchaseCommon Stock | 22,000 | $9.99 | $219,740.40 |
DisclosureSEC source: 0001140361-25-030884 · form4.xml · nonDerivative · entry 1 Smith Scott Andrew · CIK 0001614975 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 314,807 F1 · price: Represents the weighted average price of the reporting person's acquisition of 22,000 shares of common stock in transactions ranging from $9.68 to $10.12. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of common stock purchased at each separate price within the range set forth in this footnote. Read SEC document |
| June 18, 2025 Filed Jun 18, 2025 19:42 UTC | BioAtla, Inc. BCAB · Entity 879 | GrantCommon Stock | 23,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-088060 · ownership.xml · nonDerivative · entry 1 Smith Scott Andrew · CIK 0001614975 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 321,550 F1 · shares: Represents shares of Common Stock underlying a time-based restricted stock unit award ("RSU"). The RSU will vest as to 100% of the total number of shares on the earlier of (i) June 18, 2026, or (ii) the next Company annual meeting of stockholders, subject to the reporting person's continued service through the vesting date. Read SEC document |
| May 12, 2025 Filed May 14, 2025 18:00 UTC | Viatris Inc VTRS · Entity 3277 | PurchaseCommon Stock | 60,000 | $8.94 | $536,262.00 |
DisclosureSEC source: 0001140361-25-019026 · form4.xml · nonDerivative · entry 1 Smith Scott Andrew · CIK 0001614975 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 292,807 F1 · price: Represents the weighted average price of the reporting person's acquisition of 60,000 shares of common stock in transactions ranging from $8.93 to $8.94. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of common stock purchased at each separate price within the range set forth in this footnote. Read SEC document |
| March 06, 2025 Filed Mar 10, 2025 18:00 UTC | Viatris Inc VTRS · Entity 3277 | GrantRestricted Stock Units · Derivative | 373,555 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-036574 · ownership.xml · derivative · entry 1 Smith Scott Andrew · CIK 0001614975 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 373,555 Underlying: Common Stock · 373,555 shares Expires not disclosed F1 · derivative.exercise_date: Each restricted stock unit (RSU) represents the right to receive one share of common stock of Viatris Inc. 124,519 of the RSUs granted on March 6, 2025 will vest on March 6, 2026 and 124,518 will vest on each of March 6, 2027 and March 6, 2028. F1 · derivative.expiration_date: Each restricted stock unit (RSU) represents the right to receive one share of common stock of Viatris Inc. 124,519 of the RSUs granted on March 6, 2025 will vest on March 6, 2026 and 124,518 will vest on each of March 6, 2027 and March 6, 2028. Read SEC document |
| March 04, 2025 Filed Mar 5, 2025 19:00 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionDividend Equivalent Units · Derivative | 3,927.5103 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-034009 · ownership.xml · derivative · entry 12 Smith Scott Andrew · CIK 0001614975 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,854 Underlying: Common Stock · 3,927.5103 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · shares: Amount represents DEUs that accrued with respect to such RSUs in transactions exempt from Section 16 under Rule 16a-11. F11 · derivative.exercise_date: Represents DEUs that accrued with respect to the RSUs previously granted on March 4, 2024 and vest on the same schedule as the underlying RSUs. F11 · derivative.expiration_date: Represents DEUs that accrued with respect to the RSUs previously granted on March 4, 2024 and vest on the same schedule as the underlying RSUs. F8 · balance_after: Amount represents DEUs that accrued with respect to such RSUs in transactions exempt from Section 16 under Rule 16a-11. Read SEC document |
| March 04, 2025 Filed Mar 5, 2025 19:00 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionRestricted Stock Units · Derivative | 92,503 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-034009 · ownership.xml · derivative · entry 11 Smith Scott Andrew · CIK 0001614975 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 185,006 Underlying: Common Stock · 92,503 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: Each RSU represents the right to receive one share of common stock of Viatris. 92,503 of the RSUs granted on March 4, 2024 vested on March 4, 2025 and 92,503 will vest on each of March 4, 2026 and March 4, 2027. F10 · derivative.expiration_date: Each RSU represents the right to receive one share of common stock of Viatris. 92,503 of the RSUs granted on March 4, 2024 vested on March 4, 2025 and 92,503 will vest on each of March 4, 2026 and March 4, 2027. Read SEC document |
| March 04, 2025 Filed Mar 5, 2025 19:00 UTC | Viatris Inc VTRS · Entity 3277 | Tax withholdingCommon Stock | 1,546 | $9.37 | $14,486.02 |
DisclosureSEC source: 0000950170-25-034009 · ownership.xml · nonDerivative · entry 8 Smith Scott Andrew · CIK 0001614975 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 232,807 F6 · shares: Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the DEUs that accrued with respect to the RSUs previously granted on March 4, 2024. Read SEC document |
| March 04, 2025 Filed Mar 5, 2025 19:00 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionCommon Stock | 3,928 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-034009 · ownership.xml · nonDerivative · entry 7 Smith Scott Andrew · CIK 0001614975 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 234,353 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · shares: Fractional shares have been rounded up in connection with the settlement described in footnote 11 pursuant to the terms of the RSU award agreement under the Viatris Inc. 2020 Stock Incentive Plan. Read SEC document |
| March 04, 2025 Filed Mar 5, 2025 19:00 UTC | Viatris Inc VTRS · Entity 3277 | Tax withholdingCommon Stock | 36,400 | $9.37 | $341,068.00 |
DisclosureSEC source: 0000950170-25-034009 · ownership.xml · nonDerivative · entry 6 Smith Scott Andrew · CIK 0001614975 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 230,425 F4 · shares: Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the RSUs granted on March 4, 2024. Read SEC document |
| March 04, 2025 Filed Mar 5, 2025 19:00 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionCommon Stock | 92,503 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-034009 · ownership.xml · nonDerivative · entry 5 Smith Scott Andrew · CIK 0001614975 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 266,825 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 19:00 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionDividend Equivalent Units · Derivative | 10,871.8235 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-034009 · ownership.xml · derivative · entry 10 Smith Scott Andrew · CIK 0001614975 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,871 Underlying: Common Stock · 10,871.8235 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · shares: Amount represents DEUs that accrued with respect to such RSUs in transactions exempt from Section 16 under Rule 16a-11. F9 · derivative.exercise_date: Represents DEUs that accrued with respect to the RSUs previously granted on April 1, 2023 and vest on the same schedule as the underlying RSUs. F9 · derivative.expiration_date: Represents DEUs that accrued with respect to the RSUs previously granted on April 1, 2023 and vest on the same schedule as the underlying RSUs. F8 · balance_after: Amount represents DEUs that accrued with respect to such RSUs in transactions exempt from Section 16 under Rule 16a-11. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 19:00 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionRestricted Stock Units · Derivative | 135,828 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-034009 · ownership.xml · derivative · entry 9 Smith Scott Andrew · CIK 0001614975 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 135,828 Underlying: Common Stock · 135,828 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: Each RSU represents the right to receive one share of common stock of Viatris Inc. (Viatris). 135,829 of the RSUs granted on April 1, 2023 vested on March 3, 2024, 135,828 vested on March 3, 2025, and 135,828 will vest March 3, 2026. F7 · derivative.expiration_date: Each RSU represents the right to receive one share of common stock of Viatris Inc. (Viatris). 135,829 of the RSUs granted on April 1, 2023 vested on March 3, 2024, 135,828 vested on March 3, 2025, and 135,828 will vest March 3, 2026. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 19:00 UTC | Viatris Inc VTRS · Entity 3277 | Tax withholdingCommon Stock | 4,279 | $9.33 | $39,923.07 |
DisclosureSEC source: 0000950170-25-034009 · ownership.xml · nonDerivative · entry 4 Smith Scott Andrew · CIK 0001614975 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 174,322 F3 · shares: Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the dividend equivalent units (DEUs) that accrued with respect to the RSUs previously granted on April 1, 2023. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 19:00 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionCommon Stock | 10,872 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-034009 · ownership.xml · nonDerivative · entry 3 Smith Scott Andrew · CIK 0001614975 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 178,601 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Fractional shares have been rounded up in connection with the settlement described in footnote 9 pursuant to the terms of the RSU award agreement under the Viatris Inc. 2020 Stock Incentive Plan. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 19:00 UTC | Viatris Inc VTRS · Entity 3277 | Tax withholdingCommon Stock | 53,449 | $9.33 | $498,679.17 |
DisclosureSEC source: 0000950170-25-034009 · ownership.xml · nonDerivative · entry 2 Smith Scott Andrew · CIK 0001614975 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 167,729 F1 · shares: Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the restricted stock units (RSUs) granted on April 1, 2023. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 19:00 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionCommon Stock | 135,828 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-034009 · ownership.xml · nonDerivative · entry 1 Smith Scott Andrew · CIK 0001614975 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 221,178 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 31, 2024 Filed Sep 3, 2024 17:15 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 2,181 | $1.77 | $3,860.37 |
DisclosureSEC source: 0000950170-24-102925 · ownership.xml · nonDerivative · entry 1 Smith Scott Andrew · CIK 0001614975 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 298,050 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Read SEC document |
| July 31, 2024 Filed Aug 1, 2024 17:12 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 2,181 | $1.81 | $3,947.61 |
DisclosureSEC source: 0000950170-24-089427 · ownership.xml · nonDerivative · entry 1 Smith Scott Andrew · CIK 0001614975 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 300,231 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Read SEC document |
| June 30, 2024 Filed Jul 1, 2024 20:39 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 2,181 | $1.37 | $2,987.97 |
DisclosureSEC source: 0000950170-24-079916 · ownership.xml · nonDerivative · entry 1 Smith Scott Andrew · CIK 0001614975 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 302,412 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Read SEC document |
| June 13, 2024 Filed Jun 14, 2024 16:15 UTC | BioAtla, Inc. BCAB · Entity 879 | GrantCommon Stock | 16,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-073678 · ownership.xml · nonDerivative · entry 1 Smith Scott Andrew · CIK 0001614975 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 304,593 F1 · shares: Represents shares of Common Stock underlying a time-based restricted stock unit award ("RSU"). The RSU will vest as to 100% of the total number of shares on the earlier of (i) June 13, 2025, and (ii) the next Company annual meeting of stockholders, subject to the reporting person's continued service through the vesting date. Read SEC document |
| May 31, 2024 Filed May 31, 2024 20:09 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 2,181 | $1.51 | $3,293.31 |
DisclosureSEC source: 0000950170-24-067579 · ownership.xml · nonDerivative · entry 1 Smith Scott Andrew · CIK 0001614975 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 288,093 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Read SEC document |
| April 30, 2024 Filed May 1, 2024 20:45 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 2,181 | $2.26 | $4,929.06 |
DisclosureSEC source: 0000950170-24-051520 · ownership.xml · nonDerivative · entry 1 Smith Scott Andrew · CIK 0001614975 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 290,274 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Read SEC document |
| March 31, 2024 Filed Apr 1, 2024 17:01 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 2,181 | $3.44 | $7,502.64 |
DisclosureSEC source: 0000950170-24-039480 · ownership.xml · nonDerivative · entry 1 Smith Scott Andrew · CIK 0001614975 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 292,455 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Read SEC document |
| March 04, 2024 Filed Mar 5, 2024 20:01 UTC | Viatris Inc VTRS · Entity 3277 | GrantRestricted Stock Units · Derivative | 277,509 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-026620 · ownership.xml · derivative · entry 7 Smith Scott Andrew · CIK 0001614975 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 277,509 Underlying: Common Stock · 277,509 shares Expires not disclosed F7 · derivative.exercise_date: Each RSU represents the right to receive one share of common stock of Viatris. The RSUs vest in three equal annual installments beginning on March 4, 2025. F7 · derivative.expiration_date: Each RSU represents the right to receive one share of common stock of Viatris. The RSUs vest in three equal annual installments beginning on March 4, 2025. Read SEC document |
| March 03, 2024 Filed Mar 5, 2024 20:01 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionDividend Equivalent Units · Derivative | 4,897.2647 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-026620 · ownership.xml · derivative · entry 6 Smith Scott Andrew · CIK 0001614975 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,794 Underlying: Common Stock · 4,897.2647 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · shares: Amount represents DEUs that accrued with respect to such RSUs in transactions exempt from Section 16 under Rule 16a-11. F6 · derivative.exercise_date: Represents DEUs that accrued with respect to the RSUs previously granted on April 1, 2023 and vest on the same schedule as the underlying RSUs. F6 · derivative.expiration_date: Represents DEUs that accrued with respect to the RSUs previously granted on April 1, 2023 and vest on the same schedule as the underlying RSUs. F5 · balance_after: Amount represents DEUs that accrued with respect to such RSUs in transactions exempt from Section 16 under Rule 16a-11. Read SEC document |
| March 03, 2024 Filed Mar 5, 2024 20:01 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionRestricted Stock Units · Derivative | 135,829 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-026620 · ownership.xml · derivative · entry 5 Smith Scott Andrew · CIK 0001614975 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 271,656 Underlying: Common Stock · 135,829 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Each RSU represents the right to receive one share of common stock of Viatris Inc. (Viatris). 135,829 of the RSUs granted on April 1, 2023 vested on March 3, 2024, and 135,828 will vest on each of March 3, 2025 and March 3, 2026. F4 · derivative.expiration_date: Each RSU represents the right to receive one share of common stock of Viatris Inc. (Viatris). 135,829 of the RSUs granted on April 1, 2023 vested on March 3, 2024, and 135,828 will vest on each of March 3, 2025 and March 3, 2026. Read SEC document |
| March 03, 2024 Filed Mar 5, 2024 20:01 UTC | Viatris Inc VTRS · Entity 3277 | Tax withholdingCommon Stock | 1,928 | $12.59 | $24,273.52 |
DisclosureSEC source: 0000950170-24-026620 · ownership.xml · nonDerivative · entry 4 Smith Scott Andrew · CIK 0001614975 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,350 F3 · shares: Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the dividend equivalent units (DEUs) that accrued with respect to the RSUs previously granted on April 1, 2023. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.